Marks Group Wealth Management »

Vaxcyte shares owned by Marks Group Wealth Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Marks Group Wealth Management from 13F filings

Historical chart of Marks Group Wealth Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Marks Group Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Marks Group Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $381k 6.6k 58.11

More positions owned by Marks Group Wealth Management

Ishares Tr Eafe Value Etf (EFV)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Spdr Series Trust State Street Spd (SPYM)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Core Msci Emkt (IEMG)
Putnam Etf Trust Focused Lar Cap (PVAL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Republic Services (RSG)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Meta Platforms Cl A (META)
Intercontinental Exchange (ICE)

View all positions for Marks Group Wealth Management

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Geode Capital Management
Kynam Capital Management

View all funds holding Vaxcyte